azelnidipine has been researched along with Hypertension, Renal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, Y; Katayama, S; Kawamori, R; Kuramoto, K; Saito, I | 1 |
| Aoyagi, K; Hirayama, A; Koyama, A; Nagase, S; Oteki, T; Ueda, A | 1 |
| Koike, H; Miyamoto, M; Oizumi, K | 1 |
| Kimura, T; Koike, H; Miyamoto, M; Nishino, H; Oizumi, K; Sada, T | 1 |
1 trial(s) available for azelnidipine and Hypertension, Renal
| Article | Year |
|---|---|
In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabete
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Azetidinecarboxylic Acid; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension, Renal; Kidney Function Tests; Lipids; Male; Middle Aged; Thiazepines; Treatment Outcome | 2008 |
3 other study(ies) available for azelnidipine and Hypertension, Renal
| Article | Year |
|---|---|
In vivo imaging of renal redox status during azelnidipine treatment.
Topics: Animals; Antioxidants; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Creatinine; Dihydropyridines; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Hypertension, Renal; Kidney; Male; Mice; Mice, Inbred ICR; Oxidation-Reduction; Oxidative Stress | 2008 |
Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Azetidinecarboxylic Acid; Azetines; Calcium Channel Blockers; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Hypertension, Renal; Juxtaglomerular Apparatus; Male; Nephrectomy; Nicardipine; Renin; Renin-Angiotensin System | 1990 |
Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.
Topics: Anesthesia; Animals; Antihypertensive Agents; Aorta; Azetidinecarboxylic Acid; Azetines; Blood Pressure; Calcium Channel Blockers; Desoxycorticosterone; Dihydropyridines; Heart Rate; Hypertension; Hypertension, Renal; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nephrectomy; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1989 |